%0 Journal Article
%T NGP 555, a ¦Ã-secretase modulator, lowers the amyloid biomarker, A¦Â42, in cerebrospinal fluid while preventing Alzheimer's disease cognitive decline in rodents
%A Courtney Lane-Donovan
%A Dan W. Nowakowski
%A Joachim Herz
%A William T. Comer
%J Archive of "Alzheimer's & Dementia : Translational Research & Clinical Interventions".
%D 2017
%R 10.1016/j.trci.2016.09.003
%X Alzheimer's disease (AD) is defined by the progressive accumulation of amyloid plaques and neurofibrillary tangles in the brain which precedes cognitive decline by years
%K Alzheimer's
%K Amyloid
%K Modulator
%K Biomarkers
%K Pathology
%K Prevention
%K Cognition
%K Cerebrospinal fluid
%K Dementia
%K Gamma-secretase
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421551/